StockData
TDACNasdaqBlank ChecksFiscal year ends December 31Also trades as TDACU, TDACW

Translational Development Acquisition Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.81−0.02 (-0.16%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Translational Development Acquisition has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Translational Development Acquisition filed with the SEC